key: cord-1027959-oiqvfq53
authors: Cui, Zhen; Liu, Pan; Wang, Nan; Wang, Lei; Fan, Kaiyue; Zhu, Qianhui; Wang, Kang; Chen, Ruihong; Feng, Rui; Jia, Zijing; Yang, Minnan; Xu, Ge; Zhu, Boling; Fu, Wangjun; Chu, Tianming; Feng, Leilei; Wang, Yide; Pei, Xinran; Yang, Peng; Xie, Xiaoliang Sunney; Cao, Lei; Cao, Yunlong; Wang, Xiangxi
title: Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
date: 2022-01-25
journal: Cell
DOI: 10.1016/j.cell.2022.01.019
sha: d8876862ab6dc26f16df95105441faf841684c76
doc_id: 1027959
cord_uid: oiqvfq53

The SARS-CoV-2 Omicron with increased fitness is spreading rapidly worldwide. Analysis of cryo-EM structures of the Spike (S) from Omicron reveals amino acid substitutions forging interactions that stably maintain an active conformation for receptor recognition. The relatively more compact domain organization confers improved stability and enhances attachment but compromises the efficiency of the viral fusion step. Alterations in local conformation, charge and hydrophobic microenvironments underpin the modulation of the epitopes such that they are not recognized by most NTD- and RBD-antibodies, facilitating viral immune escape. Structure of the Omicron S bound with human ACE2, together with the analysis of sequence conservation in ACE2 binding region of 25 sarbecovirus members as well as heatmaps of the immunogenic sites and their corresponding mutational frequencies sheds light on conserved and structurally restrained regions that can be used for the development of broad-spectrum vaccines and therapeutics.

surface membrane protein TMPRSS2, required to fully block its entry (Hoffmann et al., 75 2020). The entry for SARS-CoV-2 involves interactions of S with the ACE2 receptor 76 and known or unidentified attachment cofactors, and subsequent priming of the protein 77 by host cell proteases (Lan et al., 2020; Shang et al., 2020; . These four previous VOCs, have been shown to be associated with an increased affinity 83 towards ACE2 (Zhou et al., 2021) . Surprisingly, the Omicron RBD has nine To further provide insights into the structural heterogeneity, we also determined near-117 atomic structures of the Delta S-trimer using the same strategy (Figures S1 and Table   118 S1). In line with WT and most variants, Delta S-trimer exhibits two distinct effects on RBD open/down disposition (Yurkovetskiy et al., 2020) . Apart from these, 141 the FPPR segment (fusion peptide proximal region, residues 828-853) and 630 loop 142 (residues 620-640) are also proposed to modulate the S stability and structural 143 rearrangements (Cai et al., 2021) . For the Omicron, the FPPR and 630 loop were well 144 resolved in the RBD-down conformation, whereas they were partially ordered in the 145 RBD-up conformation ( Figure S3 ), which is also consistent with a recent report that the representing a highly stabilized conformation ( Figure 3A ). Consequently, the Omicron 156 S-trimer possesses substantially increased intersubunit (mol A-mol B) interactions of neighboring subunits, pulling the three subunits closer ( Figure 3C ). Additionally, the 167 substitution of D796Y can stabilize the sugar at residue N709 from its adjacent subunit 168 through forming a hydrogen bond ( Figure 3D ). In line with structural observations, 169 thermal stability assays verified that the Omicron S-trimer was more stable than those 170 from WT and Delta ( Figure 3E ).

In general, improved stability, to some extent, might increase the persistence of the 173 Omicron variant in the exposed environments, posing a higher risk of transmission Figure 3F ). Analysis of the negatively stained sample showed that the Omicron S-180 trimer largely remained in the prefusion conformation and was relatively stable in 181 presence of trypsin & ACE2 at room temperature ( Figure 3F ). While the same treatment 182 led to formation of more postfusion rosettes for the Delta S-trimer, suggesting that the 183 viral fusion efficiency for the Omicron S-trimer is possibly declined ( Figure 3F ). These 184 results also largely match the experimental observations of a significant reduction in 185 syncitia formation during the Omicron infection (Meng et al., 2021) , despite the 186 presence of the P681H substitution, a similar change of P681R, which is known to favor 187 S1/S2 cleavage and enhance viral fusogenicity in Delta (Saito et al., 2021) . indicative of a considerably altered antigenic structure. The RBD and NTD are two 195 main targets of neutralization in SARS-CoV-2 and other coronaviruses (Cerutti et al., 196 2021; Dejnirattisai et al., 2021; McCallum et al., 2021; Zhang et al., 2021b) .

J o u r n a l P r e -p r o o f and partially with L452 ( Figure 5B ). Class II antibodies bind the patch between sites 238 I and III, frequently interacting with S477, T478, E484, Q493 and Y505 ( Figure 5B ).

Class IV antibodies attach to the right shoulder of RBD with relatively condensed 240 epitopes comprising residues 440-450 ( Figure 5B ). Class V and VI antibodies, 241 generally cross-reactive to sarbecoviruses, target two cryptic epitopes, consisting of 242 residues 351-357, 462-471 and residues 368-385, respectively, which are only 243 accessible when at least one RBD is in the open state ( Figure 5B ).

To gain information about the types of NAbs that could either completely lose or 246 show a dramatic reduction in neutralizing activities against Omicron, we performed 247 pseudovirus assays. The neutralization activity profile of 18 well-characterized 248 antibodies from all six classes ( Figure 5C ), except for Brii-198, whose neutralizing 249 datasets were published recently, was evaluated (Liu et al., 2021b to the Omicron S ( Figure 5D ). In addition to existing mutations like K417N, E484A 263 and N501Y, the Q493R mutation, or a similar mutation, Q493K, have previously 264 been detected through in vitro resistance mapping efforts or in immunocompromised 265 hosts (Baum et al., 2020; Choi et al., 2020; Clark et al., 2021; Focosi et al., 2021; 266 Nabel et al., 2021; Weisblum et al., 2020) . The Q493R mutation acts as one extra key Figure 6A ).

The Omicron RBD showed a 2.8-fold increased binding affinity to human ACE2 Viruses latch on to receptors using conserved residues. Many members of the β- and II type of residues within ACE2 binding sites and mutations at these positions 365 have not yet been described among circulating variants ( Figure 6E ). In other words, 366 substitutions of these hot immunogenic sites are best avoided because they probably 367 sacrifice binding activity to ACE2, which could prove to be fatal to the virus. These 

The structure of Omicron S-trimer (grey) at pH 5.5 is superimposed to Omicron S-532 trimer (red) at pH 5.5. No notable structural differences were observed except for some 533 disorder on NTD and RBM in structure solved at pH 5.5. , Alpha S-trimer (Cai et 538 al., 2021) , Beta S-trimer (Cai et al., 2021) , Gamma S-trimer (Zhang et al., 2021a) , Delta 539 S-trimer (Zhang et al., 2021a) and Omicron S-trimer were shown with each protomer The SARS-CoV-2 pseudovirus was constructed as previously described using VSV 628 pseudotyped virus (G*ΔG-VSV) (Nie et al., 2020) . SARS-CoV-2 pseudovirus carrying 629 D614G, Omicron, and Omicron (R346K) mutations was constructed and used, as 630 described previously (Cao et al., 2021) . Omicron pseudovirus contains the following Omicron RBD to AR2G biosensor was clearly detected when the amine-coupling 680 ACE2 was immobilized onto AR2G biosensor in BLI assay, which also led to 681 unreliable results. Thus, we chose SPR assay for binding affinity measurement.

Surface plasmon resonance 683 ACE2 was immobilized onto CM5 sensor chips using a Biacore T100 (GE Healthcare). The pseudovirus neutralization assays were performed using Huh-7 cell lines, as 689 described previously (Cao et al., 2020) . Briefly, various concentrations of antibodies 690 (5-fold serial dilution using DMEM) were mixed with the same volume of SARS-CoV-691 2 pseudovirus in a 96 well-plate. The mixture was incubated for 1 h at 37 °C and 692 supplied with 5% CO2. Next, pre-mixed Huh-7 cells were added to all wells, incubated 693 for 24 h at 37 °C supplied with 5% CO2. After incubation, the supernatants were 694 removed, and D-luciferin reagents (Invitrogen) were added to each well. Luciferase 695 activity was measured by using a microplate spectrophotometer (PerkinElmer EnSight).

The inhibition rate is calculated by comparing the OD value to the negative and positive 697 control wells. IC50 was determined by a four-parameter logistic regression using 698 GraphPad Prism 9.0.1 (GraphPad Software Inc.).

The WT, Delta, and Omicron S-trimer at 1 mg/ml were incubated with hACE2 at a ratio were extracted with a 320 2 -pixel box and a 360 2 -pixel box, respectively. Reference-free 725 2D alignment by cryoSPARC (Punjani et al., 2017) was applied for all the particles. contained the interfaces of RBD and hACE2 investigated here as described previously.

The resolution was determined based on the gold-standard Fourier shell correlation 746 (threshold = 0.143) and evaluated by ResMap (Kucukelbir et al., 2014) . All dataset 747 processing is shown in Figure. S2 and also summarized in Table S1 . Table S1 . 

CoV-2 neutralizing antibody structures inform therapeutic strategies

Antibody cocktail to SARS-CoV-2 spike 771 protein prevents rapid mutational escape seen with individual antibodies

Structural basis for enhanced infectivity 775 and immune evasion of SARS-CoV-2 variants

Broadly neutralizing antibodies 778 overcome SARS-CoV-2 Omicron antigenic shift

Potent Neutralizing Antibodies against SARS-CoV-2 Identified 781 by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells

B. 1.1. 529 escapes the majority of SARS-CoV-2 785 neutralizing antibodies of diverse epitopes

Potent SARS-CoV-2 neutralizing antibodies directed 788 against spike N-terminal domain target a single supersite

SARS-CoV-2 in an immunocompromised host

SARS-CoV-2 evolution in an 796 immunocompromised host reveals shared neutralization escape mechanisms

Estimated 800 transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England

The antigenic anatomy of 803 SARS-CoV-2 receptor binding domain

Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after 806 Treatment for COVID-19

Effect of natural 809 mutations of SARS-CoV-2 on spike structure

Defining variant-resistant epitopes 812 targeted by SARS-CoV-2 antibodies: A global consortium study

SARS-CoV-2 815 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease 816 inhibitor

A subset of Memory B-derived antibody 822 repertoire from 3-dose vaccinees is ultrapotent against diverse and highly 823 transmissible SARS-CoV-2 variants

Quantifying the local 825 resolution of cryo-EM density maps

Delta Variant of SARS-CoV-2: A Comparative Computational Study of Spike Protein. 828 Journal of medical virology

Characterizations of SARS-CoV-2 mutational profile, spike protein stability viral transmission

Structure of the SARS-CoV-2 spike receptor-binding domain bound 834 to the ACE2 receptor

Binding and molecular basis of the bat coronavirus RaTG13 virus 837 to ACE2 in humans and other species

Striking Antibody Evasion Manifested by the 840

Omicron Variant of SARS-CoV-2. BioRxiv

Neutralization of SARS-CoV-843

Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients. medRxiv

Structural basis for neutralization of SARS-CoV-2 and SARS-846

CoV by a potent therapeutic antibody

A broadly cross-reactive antibody 849 neutralizes and protects against sarbecovirus challenge in mice

N-terminal domain antigenic 853 mapping reveals a site of vulnerability for SARS-CoV-2

SARS-CoV-2 Omicron spike 856 mediated immune escape, infectivity and cell-cell fusion

SARS-CoV-2 B. 1.617. 2 Delta 859 variant replication and immune evasion

Structural basis for continued 862 antibody evasion by the SARS-CoV-2 receptor binding domain

Establishment and validation of a pseudovirus neutralization 865 assay for SARS-CoV-2

Antibody-mediated broad 868 sarbecovirus neutralization through ACE2 molecular mimicry

cryoSPARC: 870 algorithms for rapid unsupervised cryo-EM structure determination

Enhanced fusogenicity and 874 pathogenicity of SARS-CoV-2 Delta P681R mutation

Structural basis of receptor recognition by SARS-CoV-2

Deep mutational 880 scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and 881 ACE2 binding

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Unexpected receptor 887 functional mimicry elucidates activation of coronavirus fusion

A third dose of inactivated vaccine augments the potency, 891 breadth, and duration of anamnestic responses against SARS-CoV-2

Architecture of African swine fever virus and implications 894 for viral assembly

Antibody resistance of SARS-CoV-2 variants B. 897 1.351 and B. 1.1. 7

Structural and functional basis of SARS-CoV-2 entry by using 900 human ACE2

Escape 903 from neutralizing antibodies by SARS-CoV-2 spike protein variants

SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a 907 challenge of elimination strategy of COVID-19. The Lancet Regional Health-Western 908 Pacific

Cryo-EM structure of the 2019-nCoV spike in 911 the prefusion conformation

Structure and binding 914 properties of Pangolin-CoV spike glycoprotein inform the evolution of SARS-CoV-2

Architecture of the herpesvirus genome-packaging complex and implications 918 for DNA translocation

Structural and functional ramifications 921 of antigenic drift in recent SARS-CoV-2 variants

Structural and 924 functional analysis of the D614G SARS-CoV-2 spike protein variant

Membrane fusion and immune evasion by the 928 spike protein of SARS-CoV-2 Delta variant

A proof of concept for neutralizing antibody-931 guided vaccine design against SARS-CoV-2

SARS-CoV-2 variant B. 1.351 from natural and vaccine-induced sera

Cryo-EM structures of SARS-938

CoV-2 spike without and with ACE2 reveal a pH-dependent switch to mediate endosomal 939 positioning of receptor-binding domains

Double lock of a potent human therapeutic 942 monoclonal antibody against SARS-CoV-2

New tools for automated high-resolution cryo-EM structure 945 determination in RELION-3